Unlike T790M gatekeeper mutation predominating in EGFR‐mutant NSCLC, a much broader spectrum of on‐target mutations has been detected in ALK TKI‐resistant NSCLC. This evidence concerns the gene ALK and non-small cell lung carcinoma.